Company Profile

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, Kilitch Drugs (India) has informed that the Company has received intimation from the Registrar and Share Transfer Agents of the Company - Link Intime India for issue of duplicate share certificate as details enclosed. 

PDS’ subsidiary--- Norlanka Manufacturing India has proposed to acquire an equity stake of 5% in Frontier Knitters to expand apparel manufacturing footprint & leverage it to grow sourcing business. Cost of acquisition is Rs 1.02 crore. The said transaction is expected to be completed on or before April 30, 2024.

Mahindra & Mahindra Financial Services (Mahindra Finance) has entered into partnership with Lendingkart. This co-lending partnership is set to provide business loans for the Small & Medium Enterprise (SME) sector and will boost Mahindra Finance’s product diversification strategy, while fostering financial inclusion for small and medium enterprises.

PNC Infratech has received Letter of Acceptance (LoA) from Madhya Pradesh Public Works Department (MPPWD) through Office of Chief Engineer, PWD Bridge Zone (Authority) on February 26, 2024 for the Project of Construction of Four Lane Elevated Corridor/Flyover from Maharani Laxmibai Pratima to A.B. Road (N.H. 46) Near Girwai Police Chouki on Swarn Rekha River in Gwalior City (2nd phase) in the state of Madhya Pradesh on EPC Mode. Broad Consideration or size of the order is Rs 699 crore along with GST as applicable. The said order is expected to be completed in 36 months (including rainy season). 

Wipro and Nokia have launched joint private wireless solution to help enterprises scale their digital transformation. This joint solution will provide enterprises with a more secure 5G private wireless network solution integrated with their operation infrastructure. The solution will bring greater reliability, mobility, connectivity speed, real-time access to business insights, and the ability to process high volumes of data with low latency. Through a dedicated wireless network, enterprises will be able to create an integrated private environment they can control to better manage their performance and mitigate security risks.

ITI has signed Memorandums of Understandings (MoUs) with Lekha Wireless, Niral Networks and InstaICT Solution to create and manage entire Private 5G ecosystem for an enterprise, i.e. plan, design, deploy, implement and manage. The company has formalized a strategic collaboration with Lekha Wireless, Niral Networks, and InstaICT Solution aimed at driving the adoption of 5G technology in India. The MoUs signifies the beginning of a significant partnership between these niche entities in the telecommunications sector.

Kilitch Drug’s subsidiary -- Kilitch Estro Biotech PLC has secured a significant tender issued by the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia. This tender win marks a notable achievement for the company not only because of this tender but also it will definitely repeat as the Ethiopian Pharmaceutical Supply Service has planned to purchase injectable from local manufacturer.

Hind Rectifiers has secured supply orders from Indian Railways. The orders are to be executed by FY2024-25. The broad consideration or size of the orders is more than Rs 200 crore. 

Kilitch Drug’s subsidiary -- Kilitch Estro Biotech PLC has secured a significant tender issued by the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia. This tender win marks a notable achievement for the company not only because of this tender but also it will definitely repeat as the Ethiopian Pharmaceutical Supply Service has planned to purchase injectable from local manufacturer.

The contract awarded to Kilitch Estro Biotech PLC entails the supply of pharmaceuticals with an order size amounting to $9.13 million. The contract is executable within a timeline of six months from the receipt of the order, highlighting the efficiency and capability of the company’s subsidiary in fulfilling such large-scale contracts. This accomplishment further solidifies the company’s position in the pharmaceutical industry, showcasing its ability to secure substantial contracts and expand its presence in international markets. 

Kilitch Drugs (India) is an India-based company engaged in pharmaceutical business. The company’s services range from manufacturing to marketing a host of formulations in all dosage forms, such as solid, liquid and parenteral forms. 

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, Kilitch Drugs (India) has informed that the Company has received intimation in relation with stop transfer due to loss of share certificate by shareholder -Sumit Kumar Mathur (Folio No: 0020738) from the Registrar and Share Transfer Agents of the Company - Link Intime India. Details of the share certificate are enclosed.